[1]Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically [J]. J Urol, 1967, 97(5): 840-844.
[2]Finney RP. Re: experience with new double J ureteral catheter stent [J]. J Urol, 1979, 121(6): 838.
[3]Geavlete P, Georgescu D, Multescu R, et al. Ureteral stent complications - experience on 50,000 procedures [J]. J Med Life, 2021, 14(6): 769-775.
[4]颜媛媛,欧阳红娟,张晖辉. 长期留置双J管并发症患者应对策略的质性研究[J]. 全科护理,2019,17(20):2499-2502.
[5]Joshi HB, Stainthorpe A, Macdonagh RP, et al. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility [J]. J Urol, 2003, 169(3): 1065-1069; discussion 1069.
[6]Abt D, Dotzer K, Honek P, et al. The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ) [J]. World J Urol, 2017, 35(3): 443-447.
[7]Zhu C, Qu J, Yang L, et al. The Chinese Linguistic Validation of the Ureteral Stent Symptom Questionnaire [J]. Urol Int, 2019, 102(2): 194-198.
[8]孙刚,唐顺利,李凯,等. D-J管留置位置对患者相关的临床症状及生活质量的影响[J]. 湖北科技学院学报(医学版),2016,30(2):129-131.
[9]Kwon SY, Choi JY, Kim BS, et al. Efficacy of percutaneous nephrostomy tube during ureteroscopy for upper ureter stone management [J]. J Endourol, 2013, 27(10): 1209-1212.
[10]戚德峰,吴开俊,李逊,等. 输尿管内支架对人肾盂及膀胱压影响的研究[J]. 现代临床医学生物工程学杂志,2003,9(3):183-185.
[11]Liatsikos EN, Gershbaum D, Kapoor R, et al. Comparison of symptoms related to positioning of double-pigtail stent in upper pole versus renal pelvis [J]. J Endourol, 2001, 15(3): 299-302.
[12]杨光华,张先觉,陈士祥,等.双J管内引流在上尿路手术中的应用(附268例报告)[J].临床泌尿外科杂志,1999(6):254-255.
[13]倪永梁, 魏巍, 王祥涛, 等.输尿管支架管结壳患者尿液菌群的分布特点 [J]. 中华泌尿外科杂志,2020,41 (4): 262-266.
[14]Lopes Neto AC. Forgotten Double-J Ureteral Stent [J]. Int Braz J Urol, 2019, 45(6): 1087-1089.
[15]Abt D, Warzinek E, Schmid HP, et al. Influence of patient education on morbidity caused by ureteral stents [J]. Int J Urol, 2015, 22(7): 679-683.
[16]刘霄鹏,傅发军,彭操,等. 输尿管软镜日间手术输尿管支架留置时间研究[J]. 国际泌尿系统杂志,2020,40(1):96-98.
[17]Turk C, Petrik A, Sarica K, et al. EAU Guidelines on Interventional Treatment for Urolithiasis [J]. Eur Urol, 2016, 69(3): 475-482.
[18]Assimos D, Krambeck A, Miller NL, et al. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II [J]. J Urol, 2016, 196(4): 1161-1169.
[19]Giannarini G, Keeley FX, Jr., Valent F, et al. Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire [J]. BJU Int, 2011, 107(4): 648-654.
[20]Krambeck AE, Walsh RS, Denstedt JD, et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent [J]. J Urol, 2010, 183(3): 1037-1042.
[21]Gao L, Xu M, Zhao W, et al. Ultrathin, elastic, and self-adhesive nanofiber bio-tape: An intraoperative drug-loading module for ureteral stents with localized and controlled drug delivery properties for customized therapy [J]. Bioact Mater, 2022, 18:128-137.
[22]Oliver R, Wells H, Traxer O, et al. Ureteric stents on extraction strings: a systematic review of literature. Urolithiasis. 2018 Apr;46(2):129-136.
[23]Wang CJ, Huang SW, Chang CH. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study [J]. Urol Res, 2009, 37(3): 147-152.
[24]Liu S, Yu Y, Gao Y, et al. Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study [J]. Urolithiasis, 2016, 44(2): 185-190.
[25]高渝,胡海洋,秦国东. 索利那新联合坦索罗辛治疗输尿管支架管置入术后下尿路症状的疗效分析[J]. 海南医学,2016,27(5):725-727.
[26]Zhou L, Cai X, Li H, et al. Effects of alpha-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis [J]. J Endourol, 2015, 29(6): 650-656.
[27]朱蜀侠,王明松. 米拉贝隆联合托特罗定缓释片治疗膀胱过度活动症患者的初步临床研究[J]. 四川医学,2020,41(5):510-513.
[28]杨江华,廖晓星,赵延朋,等. 米拉贝隆治疗输尿管支架管相关症状的效果[J]. 中国医药导报,2020,17(36):91-94.